Progress in the bid to make abortion pills more widely available - The Boston Globe
Change of guidance needed for management of missed miscarriage, researchers say - The Pharmaceutical Journal
Mifepristone: Better for Managing Early Miscarriage | MedPage Today
FDA Relaxes Restrictions on Abortion Pill | MedPage Today
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada
Mifepristone (RU 486) in Cushing's syndrome in: European Journal of Endocrinology Volume 157 Issue 5 (2007)
Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda | The National Academies Press
FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores the Science and Smacks of Political Interference” - Ms. Magazine
Mifepristone - LiverTox - NCBI Bookshelf
Medchemexpress LLC HY-13683 500mg , Mifepristone RU486;RU 38486 CAS:84371-65-3 | Fisher Scientific
21 Years After FDA Approval, Abortion Pill Is More Critical Than Ever - Ms. Magazine
Abortion pill reversal' controversy heats up with new study
Mifepristone (RU486) | ≥99%(HPLC) | Selleck | Estrogen/progestogen Receptor antagonist
No Abortion Surge After Mifepristone Restrictions Dropped in Canada | MedPage Today
.jpg "What is Mifepristone? | Hey Jane | Hey Jane")
What is Mifepristone? | Hey Jane | Hey Jane
After Ohio passed abortion law, risk of complications nearly tripled - Los Angeles Times
F.D.A. Will Permanently Allow Abortion Pills by Mail - The New York Times
Mifepristone - 11β-(4-Dimethylamino)phenyl-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss | NEJM
Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study - Contraception
Mifepristone - Wikipedia
Majority of abortions in US now done with pills, data shows - ABC News
Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice – Birth Control Pharmacist
